Latest Articles

Publication Date
Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) - Seeking Alpha

Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) Seeking Alpha

Published: Aug. 17, 2026, 7:11 p.m.
Protective effect of alpha-lipoic acid against perfluorooctanoic acid-induced toxicity on the fertility of adult male mice.

Male fertility is declining, and synthetic chemicals are a major candidate for causing it. This study investigated the effect of oral consumption of perfluorooctanoic acid on sperm quality and in …

Published: Aug. 12, 2026, midnight
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer - Seeking Alpha

Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer Seeking Alpha

Published: July 30, 2026, 11:38 p.m.
The role of tumor necrosis factor alpha in regulating CYFRA 21-1 as a potential biomarker for endometriosis: A cross-sectional study.

Background: Endometriosis is one of the most common gynecological conditions, and the gold standard for its diagnosis is laparoscopy. Cytokeratin fragment 21-1 (CYFRA 21-1) has emerged as a potential biomarker …

Published: July 14, 2026, midnight
Effect of Fish-Derived Lipids on Inflammation Status and Health-Related Quality of Life in Women with Endometriosis.

Background: Endometriosis is a chronic, estrogen-dependent inflammatory disorder associated with pain and immune dysregulation. Omega-3 (n-3) fatty acids and fish-derived bioactive lipids may modulate inflammation and metabolism. This study investigated …

Published: July 5, 2026, midnight
Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com

Published: June 15, 2026, 12:29 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times

Published: June 14, 2026, 10:21 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - NTB Kommunikasjon

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 NTB Kommunikasjon

Published: June 14, 2026, 10:05 p.m.
Hypoxia-induced regulations of cell adhesion molecules and their implications for pathogenesis, diagnosis, and treatment of endometriosis.

Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissue outside the uterine cavity, affecting up to 10% of women of reproductive age. Despite extensive research, its …

Published: June 4, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!